European Journal of Public Health最新文献

筛选
英文 中文
Hepatitis B and C landscape in Uzbekistan: epidemiological patterns revealed in a study of 1 040 000 people. 乌兹别克斯坦乙型和丙型肝炎情况:一项对104万人进行的研究揭示的流行病学模式
IF 3.9 3区 医学
European Journal of Public Health Pub Date : 2025-10-01 DOI: 10.1093/eurpub/ckaf136
Umed Yusupovich Ismoilov, Erkin Isakovich Musabaev, Aziza Saidullaevna Khikmatullaeva, Nargiz Sapievna Ibadullaeva, Nataliya Georgiyevna Kan, Shakhlo Sobirovna Sadirova, Allabergan Kadirovich Bayjanov, Rano Ibrakhimovna Kasimova, Rivojiddin Khafizullaevich Juraev, Mexriniso Rizoevna Mirzoeva, Lola Umed Kizi Yusupova, Abdulaziz Baxtiyor Ugli Abdurasulov, Malika Erkinovna Khodjaeva, Shahlo Abdulloevna Sadullaevna, Oisha Shavkatovna Bobojonova, Ulugbek Khudayberdievich Mirzaev
{"title":"Hepatitis B and C landscape in Uzbekistan: epidemiological patterns revealed in a study of 1 040 000 people.","authors":"Umed Yusupovich Ismoilov, Erkin Isakovich Musabaev, Aziza Saidullaevna Khikmatullaeva, Nargiz Sapievna Ibadullaeva, Nataliya Georgiyevna Kan, Shakhlo Sobirovna Sadirova, Allabergan Kadirovich Bayjanov, Rano Ibrakhimovna Kasimova, Rivojiddin Khafizullaevich Juraev, Mexriniso Rizoevna Mirzoeva, Lola Umed Kizi Yusupova, Abdulaziz Baxtiyor Ugli Abdurasulov, Malika Erkinovna Khodjaeva, Shahlo Abdulloevna Sadullaevna, Oisha Shavkatovna Bobojonova, Ulugbek Khudayberdievich Mirzaev","doi":"10.1093/eurpub/ckaf136","DOIUrl":"10.1093/eurpub/ckaf136","url":null,"abstract":"<p><p>Uzbekistan initiated a nationwide screening program for viral hepatitis B (HBV) and C (HCV) in response to the global call for viral hepatitis elimination by 2030. This study aimed to assess HBV and HCV prevalence among the general population, provide treatment for diagnosed cases, and evaluate the effectiveness of direct-acting antiviral (DAA) therapy for HCV. From July 2022 to June 2024, 1 048 575 individuals aged 1-95 years were screened at local healthcare facilities using rapid immunochromatographic tests for hepatitis B surface antigen (HBsAg) and antibodies against hepatitis C virus (anti-HCV). Positive cases underwent confirmatory testing and were linked to care. HCV RNA-positive patients were assessed for DAA treatment eligibility. Overall HBsAg prevalence was 2.89% and anti-HCV prevalence was 3.52%. HBV prevalence decreased from 3.25% in those born before 2000 to 0.77% in those born after (P < .01), reflecting the impact of the national HBV vaccination program. Of 32 132 anti-HCV positive individuals, 20 039 (62.4%) were confirmed HCV RNA positive. Among these, 18 327 were eligible for DAA treatment. The majority received a 12-week treatment course, while 2126 (11%) with advanced liver fibrosis received a 24-week regimen. The sustained virological response rate was high, with only 1.17% of patients with advanced fibrosis and 0.96% without advanced fibrosis failing to achieve viral clearance. This large-scale study demonstrates the effectiveness of Uzbekistan's HBV vaccination program and the success of DAA treatment in achieving high cure rates for HCV. The study provides crucial data to guide public health strategies for combating viral hepatitis in Uzbekistan and progressing towards the World Health Organization's 2030 elimination targets.</p>","PeriodicalId":12059,"journal":{"name":"European Journal of Public Health","volume":" ","pages":"1014-1019"},"PeriodicalIF":3.9,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12529272/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144947935","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing the impact of chronic respiratory diseases on COVID-19 in-hospital mortality in the Italian population: a comparative study. 评估慢性呼吸道疾病对意大利人群COVID-19住院死亡率的影响:一项比较研究。
IF 3.9 3区 医学
European Journal of Public Health Pub Date : 2025-10-01 DOI: 10.1093/eurpub/ckaf149
Silvia Fattori, Giovanna Jona Lasinio, Marco Alfò, Graziano Onder, Giada Minelli
{"title":"Assessing the impact of chronic respiratory diseases on COVID-19 in-hospital mortality in the Italian population: a comparative study.","authors":"Silvia Fattori, Giovanna Jona Lasinio, Marco Alfò, Graziano Onder, Giada Minelli","doi":"10.1093/eurpub/ckaf149","DOIUrl":"10.1093/eurpub/ckaf149","url":null,"abstract":"<p><p>The COVID-19 pandemic has severely impacted Italy, leading to millions of cases and high mortality rates. Pre-existing chronic respiratory diseases may influence patient outcomes, and understanding their role is essential for improving healthcare strategies during such crises. This study analysed data from the Italian hospital discharge records database to explore the association between chronic respiratory diseases and in-hospital mortality due to COVID-19. Patients hospitalized in 2020 were studied, with exposure to respiratory diseases assessed based on hospitalizations between 2010 and 2019. Cox regression models were used to adjust for demographic and clinical factors, including age, gender, and comorbidity. Patients with pre-existing chronic respiratory diseases (n = 28 375, 13.9% of the total study population of 203 820) had a 71% higher risk (hazard ratio: 1.71, confidence interval: 1.54-1.90, P < .001) of in-hospital mortality compared to those without such conditions. Age, gender, the number of previous hospitalizations, and the Charlson comorbidity index were identified as key factors in mortality. Kaplan-Meier survival curves demonstrated significant differences in survival probabilities between exposed and unexposed groups across various age categories. Chronic respiratory diseases are associated with increased COVID-19 mortality, underscoring the need for targeted interventions in vulnerable populations to reduce the impact of future pandemics.</p>","PeriodicalId":12059,"journal":{"name":"European Journal of Public Health","volume":" ","pages":"1058-1063"},"PeriodicalIF":3.9,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12529261/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144948035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to: Prevalent findings on low-dose CT scan lung cancer screening: a French prospective pilot study. 更正:低剂量CT扫描肺癌筛查的普遍发现:一项法国前瞻性试点研究。
IF 3.9 3区 医学
European Journal of Public Health Pub Date : 2025-10-01 DOI: 10.1093/eurpub/ckaf050
{"title":"Correction to: Prevalent findings on low-dose CT scan lung cancer screening: a French prospective pilot study.","authors":"","doi":"10.1093/eurpub/ckaf050","DOIUrl":"10.1093/eurpub/ckaf050","url":null,"abstract":"","PeriodicalId":12059,"journal":{"name":"European Journal of Public Health","volume":" ","pages":"1064"},"PeriodicalIF":3.9,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12529256/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144208019","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early parental death and being not in education, employment, or training (NEET-status) in Norway: a population-wide study on the moderating role of parental education. 挪威父母过早死亡和未接受教育、就业或培训(啃老族状态):一项关于父母教育调节作用的全人口研究。
IF 3.9 3区 医学
European Journal of Public Health Pub Date : 2025-10-01 DOI: 10.1093/eurpub/ckaf081
Lamija Delalic, Jonathan Wörn, Bjørn-Atle Reme
{"title":"Early parental death and being not in education, employment, or training (NEET-status) in Norway: a population-wide study on the moderating role of parental education.","authors":"Lamija Delalic, Jonathan Wörn, Bjørn-Atle Reme","doi":"10.1093/eurpub/ckaf081","DOIUrl":"10.1093/eurpub/ckaf081","url":null,"abstract":"<p><p>Childhood parental death has been linked to adverse young adult outcomes, potentially influenced by family background. This study quantifies the association between parental death during childhood and NEET-status (not in education, employment, or training) in young adulthood, focusing on the moderating role of parental education. Causes of death were leveraged to explore the extent of confounding in the relationship between parental death and NEET-status. The study utilized Norwegian registry data from birth cohorts 1977-87 (574 229 individuals). We identified individuals with and without the experience of parental death between ages 0-17 and tracked their NEET-status between ages 22-29. Poisson regression models estimated incidence risk ratios for NEET years based on parental death, parental education, their interaction, and control variables. To address confounding, causes of death were categorized as more exogenous (i.e. neoplasms) or more endogenous (e.g. suicide or drug-related deaths). Early parental death and lower parental education were both linked to more years in NEET status. Incidence risk ratios varied by cause of death, ranging from 1.19 for neoplasms [95% confidence interval (CI): 1.13-1.25] to 2.36 for drug-related causes (95% CI: 2.17-2.56). Lower parental education amplified the association between NEET-status and parental death from most causes, but to the smallest extent for neoplasms. The association between parental death and NEET status was stronger among individuals with parents with lower parental education. When the cause of death was unrelated to parental education, the modifying effect of parental education was smaller, suggesting that stronger associations in low-education families may largely reflect confounding factors.</p>","PeriodicalId":12059,"journal":{"name":"European Journal of Public Health","volume":" ","pages":"889-895"},"PeriodicalIF":3.9,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12529293/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144590745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identifying essential COVID-19 indicators for primary healthcare through Delphi analysis in 31 European countries: Eurodata eDelphi study. 通过德尔菲分析确定31个欧洲国家初级卫生保健的基本COVID-19指标:Eurodata eDelphi研究
IF 3.9 3区 医学
European Journal of Public Health Pub Date : 2025-10-01 DOI: 10.1093/eurpub/ckaf051
Maria Pilar Astier Peña, Raquel Gómez Bravo, Ileana Gefaell Larrondo, Lourdes Ramos Del Rio, José Joaquin Mira, Snežana Knežević, Aleksandar Kirkovski, Büsra Çimen Korkmaz, Milena Kostić, Anna Krztoń-Królewiecka, Anna Segernäs, Heidrun Lingner, Liubovė Murauskienė, Achim Mortsiefer, Katarzyna Nessler, Nagu Penakacherla, Maria Pencheri, Ábel Perjés, Ferdinando Petrazzuoli, Goranka Petricek, Theresa Sentker, Lucia Palandri, Davorina Petek, Bert Vaes, Oksana Ilkov, Erva Kırkoç Üçüncü, Shlomo Vinker, Radost Assenova, Limor Adler, Maria Bakola, Sherihane Bensemmane, Ludmila Bezdíčková, Sabine Bayen, Jako S Burgers, Carmen Busneag, Georgi Tsigarovski, Asja Cosic Divjak, Philippe-Richard J Domeyer, Louise Fitzgerald, Dragan Gjorgjievski, Bruno Heleno, Kathryn Hoffmann, Marijana Jandrić-Kočić, Ana Luísa Neves, Marina Guisado-Clavero, Sara Ares-Blanco, Thomas Frese
{"title":"Identifying essential COVID-19 indicators for primary healthcare through Delphi analysis in 31 European countries: Eurodata eDelphi study.","authors":"Maria Pilar Astier Peña, Raquel Gómez Bravo, Ileana Gefaell Larrondo, Lourdes Ramos Del Rio, José Joaquin Mira, Snežana Knežević, Aleksandar Kirkovski, Büsra Çimen Korkmaz, Milena Kostić, Anna Krztoń-Królewiecka, Anna Segernäs, Heidrun Lingner, Liubovė Murauskienė, Achim Mortsiefer, Katarzyna Nessler, Nagu Penakacherla, Maria Pencheri, Ábel Perjés, Ferdinando Petrazzuoli, Goranka Petricek, Theresa Sentker, Lucia Palandri, Davorina Petek, Bert Vaes, Oksana Ilkov, Erva Kırkoç Üçüncü, Shlomo Vinker, Radost Assenova, Limor Adler, Maria Bakola, Sherihane Bensemmane, Ludmila Bezdíčková, Sabine Bayen, Jako S Burgers, Carmen Busneag, Georgi Tsigarovski, Asja Cosic Divjak, Philippe-Richard J Domeyer, Louise Fitzgerald, Dragan Gjorgjievski, Bruno Heleno, Kathryn Hoffmann, Marijana Jandrić-Kočić, Ana Luísa Neves, Marina Guisado-Clavero, Sara Ares-Blanco, Thomas Frese","doi":"10.1093/eurpub/ckaf051","DOIUrl":"10.1093/eurpub/ckaf051","url":null,"abstract":"<p><strong>Background: </strong>The COVID-19 pandemic has underlined the essential role of primary healthcare (PHC) in epidemiological surveillance and public health decision-making. Across Europe, the integration of electronic health records (EHRs) and the sentinel networks have been pivotal in monitoring COVID-19. However, the lack of standardized PHC indicators for COVID-19 hinders the comparability of data among countries.</p><p><strong>Objective: </strong>To establish a consensus on a set of standardized PHC activity indicators related to the COVID-19 pandemic for 31 countries, enhancing the capability of health authorities to make informed decisions and prepare for future health crises.</p><p><strong>Methods: </strong>A two-round eDelphi study was conducted using a structured web-based survey, following the CREDES guidelines, to achieve consensus among a panel of 164 experts from the Eurodata study. 86 Indicators were selected based on their availability during the current pandemic, with participants rating the relevance and utility of proposed indicators.</p><p><strong>Results: </strong>Of the 22 initial indicators, seven received consensuses for inclusion, while two remained contentious after the second round. The study found significant discrepancies in the awareness of sentinel networks and accessibility to PHC data. The consensus emphasized the necessity for indicators to be standardized, reproducible, and easily extractable from databases, with recommendations for disaggregation by age, sex, and vaccination status.</p><p><strong>Conclusion: </strong>Key COVID-19 indicators for PHC were identified, reflecting a consensus among healthcare professionals. Further cooperation between PHC providers and national public health authorities is warranted both on the national and the international level to harmonized healthcare indicators in response to future health emergencies.</p>","PeriodicalId":12059,"journal":{"name":"European Journal of Public Health","volume":" ","pages":"1026-1035"},"PeriodicalIF":3.9,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12529254/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144854957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Myopia and screen time: the Dutch method in addressing the epidemic with effective strategies. 近视和看屏幕时间:荷兰在有效战略应对流行病方面的方法。
IF 3.9 3区 医学
European Journal of Public Health Pub Date : 2025-10-01 DOI: 10.1093/eurpub/ckaf090
Vasanthi Iyer, Sijmen A Reijneveld
{"title":"Myopia and screen time: the Dutch method in addressing the epidemic with effective strategies.","authors":"Vasanthi Iyer, Sijmen A Reijneveld","doi":"10.1093/eurpub/ckaf090","DOIUrl":"10.1093/eurpub/ckaf090","url":null,"abstract":"","PeriodicalId":12059,"journal":{"name":"European Journal of Public Health","volume":"35 5","pages":"812-813"},"PeriodicalIF":3.9,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12529287/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145299190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The influence of case factors and system factors on the timeliness of testing and contact tracing for COVID-19 in The Netherlands. 病例因素和制度因素对荷兰COVID-19检测和接触者追踪及时性的影响
IF 3.9 3区 医学
European Journal of Public Health Pub Date : 2025-10-01 DOI: 10.1093/eurpub/ckaf109
Jizzo R Bosdriesz, Elke M den Boogert, Suzan van Dijken, Nicole H T M Dukers-Muijrers, Hannelore M Götz, Irene E Goverse, Tjalling Leenstra, Mariska W F Petrignani, Stijn F H Raven, Maarten F Schim van der Loeff, Susan van den Hof, Kirsten Wevers, Amy A Matser
{"title":"The influence of case factors and system factors on the timeliness of testing and contact tracing for COVID-19 in The Netherlands.","authors":"Jizzo R Bosdriesz, Elke M den Boogert, Suzan van Dijken, Nicole H T M Dukers-Muijrers, Hannelore M Götz, Irene E Goverse, Tjalling Leenstra, Mariska W F Petrignani, Stijn F H Raven, Maarten F Schim van der Loeff, Susan van den Hof, Kirsten Wevers, Amy A Matser","doi":"10.1093/eurpub/ckaf109","DOIUrl":"10.1093/eurpub/ckaf109","url":null,"abstract":"<p><p>Source and contact tracing (SCT) is essential to control the transmission of SARS-CoV-2, and the timeliness of SCT is crucial. As little is known about its real-world effectiveness, we investigated the timeliness of SCT in the Netherlands and its determinants. We used routine COVID-19 SCT data from all individuals who tested positive for SARS-CoV-2 at nine Dutch public health services between 1 June 2020 and 28 February 2021 (N = 384 591). We calculated median time intervals between SCT stages. We used multilevel logistic regression to study associations between case factors and system factors, and total SCT delay (symptom onset to SCT initiation >3 days), patient delay (symptom onset to making test appointment >1 day), and response delay (making test appointment to SCT initiation >2 days). The median total SCT interval time was 3 days (interquartile range 2-5). Older age and being a migrant had higher odds of delay; working in health care or education had lower odds of delay. A higher caseload and a scaled-down SCT had higher odds of delay. For age and country of birth, stronger associations with patient delay, and weaker associations with response delay were found. Although SCT during the COVID-19 pandemic might have had merits in prompting people to isolate or quarantine before the availability of a vaccine, the observed interval times indicate that SCT was not fast enough to have a large effect on interrupting transmission chains. Although promising, the added value of digital SCT tools remains uncertain.</p>","PeriodicalId":12059,"journal":{"name":"European Journal of Public Health","volume":" ","pages":"1044-1049"},"PeriodicalIF":3.9,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12529288/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144590747","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An extension of the Benefit Risk Assessment of VaccinEs toolkit to evaluate Comirnaty and Spikevax vaccination in the European Union. 扩大疫苗惠益风险评估工具包,以评估欧洲联盟的社区和Spikevax疫苗接种。
IF 3.9 3区 医学
European Journal of Public Health Pub Date : 2025-10-01 DOI: 10.1093/eurpub/ckaf135
Neilshan Loedy, Hector G Dorta, Steven Abrams, Jonas Crèvecoeur, Daniel R Morales, Catherine Cohet, Lander Willem, Geert Molenberghs, Niel Hens, Xavier Kurz, Chantal Quinten, Johan Verbeeck
{"title":"An extension of the Benefit Risk Assessment of VaccinEs toolkit to evaluate Comirnaty and Spikevax vaccination in the European Union.","authors":"Neilshan Loedy, Hector G Dorta, Steven Abrams, Jonas Crèvecoeur, Daniel R Morales, Catherine Cohet, Lander Willem, Geert Molenberghs, Niel Hens, Xavier Kurz, Chantal Quinten, Johan Verbeeck","doi":"10.1093/eurpub/ckaf135","DOIUrl":"10.1093/eurpub/ckaf135","url":null,"abstract":"<p><p>Amid the global COVID-19 pandemic, vaccines were conditionally authorized for human use to protect against severe infection. The Benefit Risk Assessment of VaccinEs (BRAVE) toolkit, a user-friendly R Shiny application, was developed retrospectively together with the European Medicine Agency (EMA) with the aim of fulfilling the need for flexible tools to assess vaccine benefits and risks during and outside a pandemic situation. This study employed BRAVE to evaluate the impact of COVID-19 mRNA vaccines across 30 European Union (EU)/EEA countries by quantifying the number of prevented clinical events [i.e. confirmed infections, hospitalizations, intensive care unit (ICU) admissions, and deaths], using a probabilistic model informed by real-time incidence data and vaccine effectiveness estimates. The analysis assumes fixed population dynamics and behaviour. Additionally, BRAVE assesses risks associated with mRNA-based vaccines (myocarditis or pericarditis) by comparing observed incidence rates in vaccinated individuals with background incidence rates. mRNA vaccines were estimated to directly prevent 11.150 million [95% confidence interval (CI): 10.876-11.345] confirmed COVID-19 infections, 0.739 million (95% CI: 0.727-0.744) COVID-19 hospitalizations, 0.107 million (95% CI: 0.104-0.109) ICU admissions, and 0.187 million (95% CI: 0.182-0.189) COVID-19-related deaths in the EU/EEA between 13 December 2020 and 31 December 2021. Despite increased vaccination-associated myocarditis or pericarditis observed in younger men, the benefits of vaccination still outweigh these risks. Our study supports the benefit/risk profile of COVID-19 vaccines and emphasizes the utility of employing a flexible toolkit to assess risks and benefits of vaccination. This user-friendly and adaptable toolkit can serve as a blueprint for similar tools, enhancing preparedness for future public health crises.</p>","PeriodicalId":12059,"journal":{"name":"European Journal of Public Health","volume":" ","pages":"1007-1013"},"PeriodicalIF":3.9,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12529280/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144882417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of specialist palliative care on utilization of healthcare and social services at the end-of-life: a nationwide register-based cohort study. 专科姑息治疗对临终医疗保健和社会服务利用的影响:一项全国性的基于登记的队列研究。
IF 3.9 3区 医学
European Journal of Public Health Pub Date : 2025-10-01 DOI: 10.1093/eurpub/ckaf044
Satu E Ahtiluoto, Timo P Carpén, Pirita T Forsius, Mikko S J Nuutinen, Nelli-Sofia A Nåhls, Pauliina M Kitti, Teija H Hammar, Harriet U Finne-Soveri, Tiina H Saarto
{"title":"Impact of specialist palliative care on utilization of healthcare and social services at the end-of-life: a nationwide register-based cohort study.","authors":"Satu E Ahtiluoto, Timo P Carpén, Pirita T Forsius, Mikko S J Nuutinen, Nelli-Sofia A Nåhls, Pauliina M Kitti, Teija H Hammar, Harriet U Finne-Soveri, Tiina H Saarto","doi":"10.1093/eurpub/ckaf044","DOIUrl":"10.1093/eurpub/ckaf044","url":null,"abstract":"<p><p>Non-malignant diseases cause 60% of non-communicable diseases requiring palliative care, yet specialist palliative care services primarily focus on cancer. We investigated end-of-life healthcare and social services utilization among cancer and non-malignant patients, and, secondarily, access to specialist palliative care and its effect on services utilization. This retrospective, nationwide register-based study included all adults (n = 38 540) who died from non-communicable life-limiting diseases in Finland in 2019, categorized into neurodegenerative (31%), other non-malignant (36%), and cancer (33%) groups. Hospital was the most common place of death (61%). Healthcare utilization substantially increased during the final weeks of life in all groups but remained highest in cancer patients. Social services utilization was highest in neurodegenerative diseases. Specialist palliative care contact was significantly (P < .001) higher in cancer (30.1%) compared to neurodegenerative (10.9%) and other non-malignant (7%) diseases. Early (>30 days before death) compared to late/no specialist palliative care contact significantly reduced emergency care contacts (47.8% vs. 52.2%) and hospitalizations in secondary hospitals (24.7% vs. 33.7%), and increased specialist palliative care ward (15.5% vs. 1.5%) and hospital-at-home (36.8% vs. 3.4%) utilization during the final month (P < .001). Healthcare utilization was high in all disease groups, highest among cancer patients. Hospital was the most common place of death. Specialist palliative care contact was rare in non-malignant diseases. Early contact with specialist palliative care associated with lower emergency care utilization and secondary hospital inpatient care during the last month of life. These results highlight the necessity for timely equitable specialist palliative care services for all.</p>","PeriodicalId":12059,"journal":{"name":"European Journal of Public Health","volume":" ","pages":"828-834"},"PeriodicalIF":3.9,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12529283/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144157405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of the COVID-19 pandemic on five food- and waterborne diseases in six European countries, 2016-21. 2016-21年COVID-19大流行对六个欧洲国家五种食物和水传播疾病的影响。
IF 3.9 3区 医学
European Journal of Public Health Pub Date : 2025-10-01 DOI: 10.1093/eurpub/ckaf101
Johanna J Young, Martine Grosos Aabye, Ondrej Daniel, Michaela Špačková, Theologia Sideroglou, Kassiani Mellou, Anthi Chrysostomou, Ingrid H M Friesema, Eelco Franz, Heidi Lange, Trude M Lyngstad, Lin T Brandal, Nadja Karamehmedovic, Rikard Dryselius, Steen Ethelberg, Therese Westrell
{"title":"Impact of the COVID-19 pandemic on five food- and waterborne diseases in six European countries, 2016-21.","authors":"Johanna J Young, Martine Grosos Aabye, Ondrej Daniel, Michaela Špačková, Theologia Sideroglou, Kassiani Mellou, Anthi Chrysostomou, Ingrid H M Friesema, Eelco Franz, Heidi Lange, Trude M Lyngstad, Lin T Brandal, Nadja Karamehmedovic, Rikard Dryselius, Steen Ethelberg, Therese Westrell","doi":"10.1093/eurpub/ckaf101","DOIUrl":"10.1093/eurpub/ckaf101","url":null,"abstract":"<p><p>The COVID-19 pandemic required a shift in healthcare and public health focus and led to numerous public health measures also affecting food- and waterborne diseases (FWDs). We describe the impact of the pandemic using the number of confirmed domestically-acquired and travel-related cases of campylobacteriosis, salmonellosis, hepatitis A, shigellosis, and listeriosis notified to ECDC between 2016 and 2021 by Czechia, Denmark, Greece, the Netherlands, Norway, and Sweden. We compared the monthly median number of cases from the pre-pandemic period to those during the pandemic. We used data on international travel controls from the Oxford COVID-19 Government Response Tracker to assess the impact of travel-related measures on these diseases across the countries. This study emphasizes the substantial differences in transmission routes, surveillance, notification and detection methodologies, as well as testing and sampling practices of these diseases across the different countries. Despite these variations, the overall recorded case numbers for most of the five FWDs decreased during the pandemic (March 2020-December 2021), except for the more severe disease listeriosis, suggesting that health-seeking behaviour and healthcare access played a role in the decline of FWDs with milder symptoms. The proportion of travel-associated cases decreased for most diseases in all countries, particularly for campylobacteriosis and salmonellosis, likely due to the travel restrictions. Declines were also observed in the number of domestically-acquired cases. An improved understanding of healthcare-seeking behaviour and testing rates during the pandemic can provide insights into the extent of under-diagnosis in the reduction of cases.</p>","PeriodicalId":12059,"journal":{"name":"European Journal of Public Health","volume":" ","pages":"1036-1043"},"PeriodicalIF":3.9,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12529296/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144667486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信